All In Biotech

Drug Trial Radar · NCT07509307

AMAZE 6: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Knee Osteoarthritis Lose Weight and Reduce Pain

Efficacy and Safety of NNC0487-0111 s.c. Once-weekly in Participants With Overweight or Obesity, and Knee Osteoarthritis (AMAZE 6)

Last checked: Nov 20, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 400 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

400

Planned (sponsor's estimate)

Start

Apr 20, 2026

Primary completion

Aug 14, 2028

Study completion Aug 14, 2028

Sponsor

Lead sponsor
Novo Nordisk A/SNovo Nordisk (NVO)
Sponsor type
Industry
First posted
Apr 3, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study is being done to look at the safety and effect of NNC0487-0111 in people with excess body weight and knee osteoarthritis when compared to placebo. There are 2 study treatments in this study taken as injections under the skin once a week. Participants will either get NNC0487-0111, (the treatment being tested) or Placebo (a treatment that has no active medicine in it). Which treatment participants get is decided by chance.

Conditions

  • Obesity
  • Overweight
  • Osteoarthritis, Knee

Interventions

  • NNC0487-0111Drug

    NNC0487-0111 will be administered subcutaneously using PDS290 pre-filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.

  • Placebo (matched to NNC0487-0111)Drug

    Placebo matched to NNC0487-0111 will be administered subcutaneously using PDS290 pre-filled pen-injectors to one of the body parts: thigh, abdomen or upper arm.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Relative change in body weightTime frame: From baseline (week 0) to week 80
  2. Change in Western Ontario and McMaster Universities Osteoarthritis Index Numerical Rating Scale (NRS) 3.1 (24-hour) (WOMAC) pain scoreTime frame: From baseline (week 0) to week 80

Locations

81 sites in 11 countries. Site status is shown where the registry gives one.

  • Neighborhood Healthcare

    Escondido, California · Recruiting

  • First Valley Medical Group

    Lancaster, California · Recruiting

  • Desert Oasis Healthcare

    Palm Springs, California · Recruiting

  • Chase Medical Research LLC

    Waterbury, Connecticut · Recruiting

  • Westside Center For Clinical Research

    Jacksonville, Florida · Recruiting

  • Clinical Neuroscience Solutions, LLC

    Jacksonville, Florida · Recruiting

  • Advanced Res for Health Improve

    Naples, Florida · Recruiting

  • Clinical Investigation Spec Gurnee

    Gurnee, Illinois · Recruiting

  • Evanston Premier Hlthcr Res

    Skokie, Illinois · Recruiting

  • Monroe Biomedical Research, LLC

    Louisville, Kentucky · Recruiting

  • Arcturus Healthcare, PLC.

    Troy, Michigan · Recruiting

  • Clinvest Research

    Springfield, Missouri · Recruiting

  • NYU Langone Orthopedic Center

    New York, New York · Not yet recruiting

  • Hospital For Special Surgery

    New York, New York · Recruiting

  • Piedmont Healthcare/Research

    Statesville, North Carolina · Recruiting

  • Northwest Research Center

    Portland, Oregon · Recruiting

  • Mercy Family Clinic

    Dallas, Texas · Recruiting

  • Health Res of Hampton Roads

    Newport News, Virginia · Recruiting

  • Northwest Clinical Research Center

    Bellevue, Washington · Recruiting

  • Emeritus Research Sydney

    Botany, New South Wales, Australia · Recruiting

  • Momentum Clinical Research Darlinghurst

    Darlinghurst, New South Wales, Australia · Recruiting

  • Kolling Institute

    St Leonards, New South Wales, Australia · Recruiting

  • Heart of Australia

    Chelmer, Queensland, Australia · Recruiting

  • Coastal Digestive Health

    Maroochydore, Queensland, Australia · Recruiting

  • UMHAT Sveti Georgi EAD, Plovdiv

    Plovdiv, Bulgaria · Recruiting

  • MC Dr. Atanasov EOOD

    Sofia, Bulgaria · Recruiting

  • MC Excelsior OOD

    Sofia, Bulgaria · Recruiting

  • UMHAT Tsaritsa Yoanna - ISUL EAD, Orthopaedics and Traumatology

    Sofia, Bulgaria · Recruiting

  • MMA MHAT - Sofia, Rheumatology clinic

    Sofia, Bulgaria · Recruiting

  • UMHAT Sveti Ivan Rilski EAD, Rheumatology

    Sofia, Bulgaria · Recruiting

  • TLC Diabetes and Endocrinology

    Surrey, British Columbia, Canada · Not yet recruiting

  • Your Research Network

    Niagara Falls, Ontario, Canada · Recruiting

  • ALPHA Recherche Clinique

    Lévis, Quebec, Canada · Recruiting

  • Centre Medical Acadie

    Montreal, Quebec, Canada · Recruiting

  • ALPHA Recherche Clinique

    Québec, Quebec, Canada · Recruiting

  • Centre de Recherche du CHUS

    Sherbrooke, Quebec, Canada · Recruiting

  • Aarhus Universitetshospital - Klinik for Led og bindevævssygdomme

    Aarhus N, Denmark · Recruiting

  • Frederiksberg Hospital - Parker Institutet (Artrose)

    Frederiksberg, Denmark · Recruiting

  • Sanos Clinic - Herlev

    Herlev, Denmark · Recruiting

  • Evangelismos S.A. - Endocrinology department

    Athens, Greece · Recruiting

Showing 40 of 81 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.